Enable JavaScript to visit this website.

Finding your new normal

As a woman diagnosed with metastatic breast cancer (MBC), a lot may have changed – but a lot hasn’t.

IBRANCE® is the #1 prescribed, FDA-approved oral combination treatment for women with HR+, HER2- MBC.

 

IBRANCE® is the #1 prescribed,
FDA-approved
oral combination
treatment for women with HR+,
HER2- metastatic breast cancer.

Learn More

INDICATIONS: IBRANCE is a prescription medicine used to treat HR+, HER2- breast cancer that has spread to other parts of the body (metastatic) in combination with an aromatase inhibitor as the first hormonal based therapy in women who have gone through menopause, or fulvestrant in women with disease progression following hormonal therapy.

Eligible Patients Pay No More Than $10 Per Month* For IBRANCE

Limits, terms, and conditions apply. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Please visit PfizerCoPayOne.com or see savings card for complete terms and conditions. For any questions, please call 1-855-612-1951 or visit PfizerCoPayOne.com. Pfizer Co-Pay One Savings Card, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.

Get To Know Women Taking IBRANCE
Support, Resources, And Insights To Help You Learn More About IBRANCE

IBRANCE Answers delivers facts and resources to help you understand more about IBRANCE and find helpful support throughout treatment.

Support and resources for a treatment for a certain type of MBC